Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05245760
Title ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer (CRATER)
Acronym CRATER
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Zhonglin Hao
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.